IBDEI1PQ ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,30339,0)
 ;;=O36.1925^^178^1916^157
 ;;^UTILITY(U,$J,358.3,30339,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30339,1,3,0)
 ;;=3^Maternal care for oth isoimmun, second trimester, fetus 5
 ;;^UTILITY(U,$J,358.3,30339,1,4,0)
 ;;=4^O36.1925
 ;;^UTILITY(U,$J,358.3,30339,2)
 ;;=^5016930
 ;;^UTILITY(U,$J,358.3,30340,0)
 ;;=O36.1930^^178^1916^158
 ;;^UTILITY(U,$J,358.3,30340,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30340,1,3,0)
 ;;=3^Maternal care for oth isoimmun, third trimester, unsp
 ;;^UTILITY(U,$J,358.3,30340,1,4,0)
 ;;=4^O36.1930
 ;;^UTILITY(U,$J,358.3,30340,2)
 ;;=^5016931
 ;;^UTILITY(U,$J,358.3,30341,0)
 ;;=O36.1931^^178^1916^159
 ;;^UTILITY(U,$J,358.3,30341,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30341,1,3,0)
 ;;=3^Maternal care for oth isoimmun, third trimester, fetus 1
 ;;^UTILITY(U,$J,358.3,30341,1,4,0)
 ;;=4^O36.1931
 ;;^UTILITY(U,$J,358.3,30341,2)
 ;;=^5016932
 ;;^UTILITY(U,$J,358.3,30342,0)
 ;;=O36.1932^^178^1916^160
 ;;^UTILITY(U,$J,358.3,30342,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30342,1,3,0)
 ;;=3^Maternal care for oth isoimmun, third trimester, fetus 2
 ;;^UTILITY(U,$J,358.3,30342,1,4,0)
 ;;=4^O36.1932
 ;;^UTILITY(U,$J,358.3,30342,2)
 ;;=^5016933
 ;;^UTILITY(U,$J,358.3,30343,0)
 ;;=O36.1933^^178^1916^161
 ;;^UTILITY(U,$J,358.3,30343,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30343,1,3,0)
 ;;=3^Maternal care for oth isoimmun, third trimester, fetus 3
 ;;^UTILITY(U,$J,358.3,30343,1,4,0)
 ;;=4^O36.1933
 ;;^UTILITY(U,$J,358.3,30343,2)
 ;;=^5016934
 ;;^UTILITY(U,$J,358.3,30344,0)
 ;;=O36.1934^^178^1916^162
 ;;^UTILITY(U,$J,358.3,30344,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30344,1,3,0)
 ;;=3^Maternal care for oth isoimmun, third trimester, fetus 4
 ;;^UTILITY(U,$J,358.3,30344,1,4,0)
 ;;=4^O36.1934
 ;;^UTILITY(U,$J,358.3,30344,2)
 ;;=^5016935
 ;;^UTILITY(U,$J,358.3,30345,0)
 ;;=O36.1935^^178^1916^163
 ;;^UTILITY(U,$J,358.3,30345,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30345,1,3,0)
 ;;=3^Maternal care for oth isoimmun, third trimester, fetus 5
 ;;^UTILITY(U,$J,358.3,30345,1,4,0)
 ;;=4^O36.1935
 ;;^UTILITY(U,$J,358.3,30345,2)
 ;;=^5016936
 ;;^UTILITY(U,$J,358.3,30346,0)
 ;;=O77.9^^178^1916^17
 ;;^UTILITY(U,$J,358.3,30346,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30346,1,3,0)
 ;;=3^Labor/delivery comp by fetal stress, unspecified
 ;;^UTILITY(U,$J,358.3,30346,1,4,0)
 ;;=4^O77.9
 ;;^UTILITY(U,$J,358.3,30346,2)
 ;;=^5017750
 ;;^UTILITY(U,$J,358.3,30347,0)
 ;;=O77.8^^178^1916^18
 ;;^UTILITY(U,$J,358.3,30347,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30347,1,3,0)
 ;;=3^Labor/delivery comp by oth evidence of fetal stress
 ;;^UTILITY(U,$J,358.3,30347,1,4,0)
 ;;=4^O77.8
 ;;^UTILITY(U,$J,358.3,30347,2)
 ;;=^5017749
 ;;^UTILITY(U,$J,358.3,30348,0)
 ;;=O68.^^178^1916^16
 ;;^UTILITY(U,$J,358.3,30348,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30348,1,3,0)
 ;;=3^Labor/delivery comp by abnlt of fetal acid-base balance
 ;;^UTILITY(U,$J,358.3,30348,1,4,0)
 ;;=4^O68.
 ;;^UTILITY(U,$J,358.3,30348,2)
 ;;=^5017638
 ;;^UTILITY(U,$J,358.3,30349,0)
 ;;=O36.4XX0^^178^1916^121
 ;;^UTILITY(U,$J,358.3,30349,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30349,1,3,0)
 ;;=3^Maternal care for intrauterine death, not applicable or unsp
 ;;^UTILITY(U,$J,358.3,30349,1,4,0)
 ;;=4^O36.4XX0
 ;;^UTILITY(U,$J,358.3,30349,2)
 ;;=^5016970
 ;;^UTILITY(U,$J,358.3,30350,0)
 ;;=O36.4XX1^^178^1916^116
 ;;^UTILITY(U,$J,358.3,30350,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30350,1,3,0)
 ;;=3^Maternal care for intrauterine death, fetus 1
 ;;^UTILITY(U,$J,358.3,30350,1,4,0)
 ;;=4^O36.4XX1
 ;;
 ;;$END ROU IBDEI1PQ
